| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |